Revolutionizing Diagnostics: Evaluating ChatGPT-4's Performance in Ulcerative Colitis Endoscopic Assessment

Endoscopy 2025; 57(S 02): S433
DOI: 10.1055/s-0045-1806108

Abstracts | ESGE Days 2025

ePosters

A Levartovsky

¹Sheba medical Center, Ramat Gan, Israel

,

A Albshesh

¹Sheba medical Center, Ramat Gan, Israel

,

G Ana

¹Sheba medical Center, Ramat Gan, Israel

,

S Eyal

¹Sheba medical Center, Ramat Gan, Israel

,

A Lahat

²Assuta Hospital Ashdod University hospital, Ashdod, Israel

,

R Eliakim

¹Sheba medical Center, Ramat Gan, Israel

,

U Kopylov

¹Sheba medical Center, Ramat Gan, Israel

References
1 Osada T, Ohkusa T, Yokoyama T. et al. Comparison of several activity indices for the evaluation of endoscopic activity in UC: Inter- and intraobserver consistency. Inflamm Bowel Dis 2010; 16 (2): 192-197
2 Turner D, Ricciuto A, Lewis A. et al. STRIDE-II: An Update on the Selecting Therapeutic Targets in In fl ammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD. 2021; 1570-1583
3 Schroeder K, Tremanie W, Ilstrup D.. Coated Oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med 1987; 317 (26): 1625-1629